Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Durability and lightweight are the meritorious features that increase the demand for portable nitric oxide therapy systems. Relatively low cost, versatility and easy fabrication of the auxiliary holding devices with the main ventilation unit makes fixed nitric oxide therapy systems a lucrative option in the ambulatory care and hospitals.
Hospitals and clinics widely utilize the nitric oxide inhalation therapy in the neonate and intensive care unit to address ailments related to pulmonary disorders and increasing demand for pediatric cardiopulmonary bypass surgery procedures for treating cardiopulmonary ailments. Homecare settings finds huge application of nitric oxide therapy systems for the rehabilitation of geriatric patients suffering with acute respiratory distress syndrome.
North America is the market leader in nitric oxide therapy systems due to the rising prevalence of acute respiratory distress syndrome in the adult population and the presence of key players actively engaged in the manufacturing of nitric oxide therapy systems. Asia Pacific will dominate the market in the near future on account of the rising prevalence of neonate pulmonary hypertension. Competitive market formed due to the emergence of local providers of nitric oxide therapy systems contribute to the growth of Asia Pacific market.
The report offers detailed coverage of Nitric Oxide Therapy System industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Nitric Oxide Therapy System by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
The report forecast global Nitric Oxide Therapy System market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Nitric Oxide Therapy System market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Bellerophon Therapeutics
BOC Healthcare
Dan Hammer Health LTD
EKU Elektronik GmbH
GeNO LLC
International Biomedical
SLE
Mallinckrodt Pharmaceuticals
Praxair, Inc.
Vapotherm
At the same time, we classify Nitric Oxide Therapy System according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Protable System
Fixed System
Market by Application
Hospitals
Homecare Settings
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Nitric Oxide Therapy System market for the forecast period 2021 - 2025?
• What are the driving forces in the Nitric Oxide Therapy System market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Nitric Oxide Therapy System industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?